BACKGROUND: India carries one quarter of the global burden of multi-drug resistant TB (MDR-TB) and has an estimated 2.5 million people living with HIV. Despite this reality, provision of treatment for MDR-TB is extremely limited, particularly for HIV-infected individuals. Médecins Sans Frontières (MSF) has been treating HIV-infected MDR-TB patients in Mumbai since May 2007. This is the first report of treatment outcomes among HIV-infected MDR-TB patients in India. METHODS: HIV-infected patients with suspected MDR-TB were referred to the MSF-clinic by public Antiretroviral Therapy (ART) Centers or by a network of community non-governmental organizations. Patients were initiated on either empiric or individualized second-line TB-treatment as ...
Drug-resistant tuberculosis (DR-TB) is a looming threat to tuberculosis control in India. However, n...
Setting: Tuberculosis Research Centre clinics at Chennai and Madurai, Tamil Nadu, South India. Objec...
There is paucity of data from India on the impact of HIV related immunosuppression in response to TB...
India carries one quarter of the global burden of multi-drug resistant TB (MDR-TB) and has an estima...
India carries one quarter of the global burden of multi-drug resistant TB (MDR-TB) and has an estima...
BACKGROUND: Drug-resistant tuberculosis (DR-TB) is a looming threat to tuberculosis control in India...
Drug-resistant tuberculosis (DR-TB) is a looming threat to tuberculosis control in India. However, n...
BACKGROUND: Little is known about the treatment of multidrug-resistant tuberculosis (MDR-TB) in HIV-...
Multidrug-resistant tuberculosis (MDR-TB) is a major clinical challenge, particularly in patients wi...
BACKGROUND:HIV-infected persons suffering from tuberculosis experience high mortality. No programmat...
Background: Developing countries like India are heavily burdened with multidrug resistant tuberculos...
Significant adverse events (AE) have been reported in patients receiving medications for multidrug- ...
Significant adverse events (AE) have been reported in patients receiving medications for multidrug- ...
HIV-infected persons suffering from tuberculosis experience high mortality. No programmatic studies ...
Background: Little is known about the treatment of multidrug-resistant tuberculosis (MDR-TB) in HIV-...
Drug-resistant tuberculosis (DR-TB) is a looming threat to tuberculosis control in India. However, n...
Setting: Tuberculosis Research Centre clinics at Chennai and Madurai, Tamil Nadu, South India. Objec...
There is paucity of data from India on the impact of HIV related immunosuppression in response to TB...
India carries one quarter of the global burden of multi-drug resistant TB (MDR-TB) and has an estima...
India carries one quarter of the global burden of multi-drug resistant TB (MDR-TB) and has an estima...
BACKGROUND: Drug-resistant tuberculosis (DR-TB) is a looming threat to tuberculosis control in India...
Drug-resistant tuberculosis (DR-TB) is a looming threat to tuberculosis control in India. However, n...
BACKGROUND: Little is known about the treatment of multidrug-resistant tuberculosis (MDR-TB) in HIV-...
Multidrug-resistant tuberculosis (MDR-TB) is a major clinical challenge, particularly in patients wi...
BACKGROUND:HIV-infected persons suffering from tuberculosis experience high mortality. No programmat...
Background: Developing countries like India are heavily burdened with multidrug resistant tuberculos...
Significant adverse events (AE) have been reported in patients receiving medications for multidrug- ...
Significant adverse events (AE) have been reported in patients receiving medications for multidrug- ...
HIV-infected persons suffering from tuberculosis experience high mortality. No programmatic studies ...
Background: Little is known about the treatment of multidrug-resistant tuberculosis (MDR-TB) in HIV-...
Drug-resistant tuberculosis (DR-TB) is a looming threat to tuberculosis control in India. However, n...
Setting: Tuberculosis Research Centre clinics at Chennai and Madurai, Tamil Nadu, South India. Objec...
There is paucity of data from India on the impact of HIV related immunosuppression in response to TB...